Navigation Links
University of Ottawa Heart Institute is North America's First Clinical Site for Ultra-sophisticated X-Ray
Date:4/16/2009

New Technology Cuts Radiation Exposure, Reduces Procedure Time, Lowers

Costs

OTTAWA, April 16 /PRNewswire/ - The University of Ottawa Heart Institute (UOHI) has installed North America's first dual axis rotational cardiac X-ray for clinical use, allowing physicians to more clearly locate and diagnose blockage in the heart's arteries. The ultra-sophisticated equipment cuts radiation exposure by 33%, reduces X-ray time by a similar amount and offers other benefits.

"The Heart Institute typically conducts 6,000 catheterizations each year and we can further decrease the waiting period for our heart patients", said Dr. Marino Labinaz, Director, Cardiac Catheterization Laboratory, UOHI. "As part of our research mandate, we are also planning to investigate the full impact of this advanced X-ray technology on patient risk and improved effectiveness."

Diagnosing coronary blockage through a procedure called cardiac catheterization is traditionally performed by taking six or seven different X-ray views. In each case, dye is injected into the coronary artery. Each injection takes time - to set up and to make the injection. With the new rotational X-ray, only one injection is needed to cover all views, requiring up to 20 per cent less dye. This is significant because the dye can cause potential damage in patients with kidney problems.

The new X-ray system quickly rotates around the patient, giving medical teams the ability to more easily view live 3-D images of the arteries in a manner that improves the quality of diagnosis and treatment. In turn, this approach reduces the length of the procedure - leaving more time for other patients and helping to boost patient throughput. The advanced nature of the equipment also lowers the amount of radiation required to image the arteries by up to 33%, helping to reduce potential radiation risks for patients.

The X-ray system is part of a new generation of imaging equipment that provides patients at the Heart Institute with improved accuracy and speed in the diagnosis and treatment of coronary artery disease. The Heart Institute is the first clinical site in North America and one of a handful of cardiac catheterization facilities in the world to employ the dual axis rotational X-ray.

"Patients at the Heart Institute continue to benefit from the most advanced practices, technologies and treatments in coronary artery disease," said Dr. Labinaz. "As this technology gets adopted elsewhere, our research knowledge and experience will reduce the learning curve for other clinical centres which, in turn, will benefit patients across the country."

About UOHI

The University of Ottawa Heart Institute is Canada's largest and foremost cardiovascular health centre dedicated to understanding, treating and preventing heart disease. We deliver high-tech care with a personal touch, shape the way cardiovascular medicine is practiced, and revolutionize cardiac treatment and understanding. We build knowledge through research and translate discoveries into advanced care. We serve the local, national and international community, and are pioneering a new era in heart health. For more information, visit www.ottawaheart.ca

EDITORS: An accompanying photo is available.

    /NOTE TO PHOTO EDITORS: A photo accompanying this release is available on
    the CNW Photo Network and archived athttp://photos.newswire.ca.
    Additional archived images are also available on the CNW Photo Archive
    website athttp://photos.newswire.ca. Images are free to accredited
    members of the media/

'/>"/>
SOURCE OTTAWA HEART INSTITUTE, UNIVERSITY OF OTTAWA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Joseph A. Califano, Jr., Chairman and President, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education and Welfare on New York States Action Council
2. American Airlines Applauded for Its Fundraising to Support Susan G. Komen for the Cure(R), Promise Grant to The University of Texas M. D. Anderson Cancer Center
3. American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration
4. iZumi Bio and Kyoto University Form Collaboration to Advance Induced Pluripotent Stem Cell Technology
5. Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Loma Linda University Research
6. Western Governors University to Launch Nations First Competency-Based B.S. in Nursing Leading to RN Licensure
7. University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum
8. Dialysis Corporation of America Announces Establishment of Clinical Grant Agreement with the University of Cincinnati, College of Medicine
9. Rush University Medical Center orthopaedic experts examine overhead
10. UT Southwestern University Hospital earns outstanding achievement award for cancer care
11. University of Tennessee Medical Center Saves 60 Percent on IT Costs With Unified Email Management by Mimecast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: